Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TG-C in Osteoarthritis of the Knee
NCT03291470Phase 3Completed
- Sponsor
- Kolon TissueGene, Inc.
- Start
- Dec 2021
- Primary completion
- Mar 2024
- Modality
- Gene Editing, Gene Silencing, Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of Invossa in osteoarthritis (OA), sponsored by Kolon TissueGene, Inc.. Started Dec 2021; status: completed.
02
Drugs
Invossa
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03291470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03291470.